Skip to main content
Erschienen in: Indian Journal of Gastroenterology 4/2014

01.07.2014 | Original Article

Central venous pressure catheter for large-volume paracentesis in refractory ascites

verfasst von: Shahram Agah, Sahar Tavakoli, Hajar Nikbakht, Mehrdokht Najafi, Abdolreza Al-agha

Erschienen in: Indian Journal of Gastroenterology | Ausgabe 4/2014

Einloggen, um Zugang zu erhalten

Abstract

Background and Aims

About 10 % of cirrhotic patients are unresponsive to sodium restriction and diuretics and develop refractory ascites. Such patients usually require recurrent large-volume paracentesis and lots of hospital admissions. Hereby, we introduce a method applying a central vein (CV) catheter for large-volume paracentesis in patients with refractory ascites in up to 4 days associated with sodium restriction and high dose of diuretics.

Methods

Non-tunneled triple lumen CV catheter was used to drain the ascites fluid of 30 cirrhotic patients. After precise percussion, the point of highest fluid accumulation was marked for puncture. Then, the skin and subcutaneous tissue were anesthetized. CV catheter set guide wire was entered into the peritoneal cavity and the dilator of the CV catheter set was passed through the guide wire and extracted after some rotations around its insertion site on the skin. The catheter was passed over the guide wire and the guide wire was extracted gradually from one of the lumens and fixed to the skin.

Results

Nineteen males and 11 females with mean (±SD) age of 59.4 ± 11.7 years old underwent the procedure. A minimum of 9 and maximum of 29 L (12 ± 6.6 L) ascites fluid drained during a minimum of 2 and maximum of 5 days of hospital stay. All catheters were patent during the drainage. None of the patients developed hemodynamic instability. Number of re-hospitalizations for paracentesis was 1.9 times during the following year. No complication occurred.

Conclusions

This technique is a simple noninvasive method that can be performed in the endoscopy unit or even at the patient’s bedside and may reduce the need for repeated admissions.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Kim WR, Brown JR, Terrault NA, et al. Burden of liver disease in the United States: summary of the workshop. Hepatology. 2002;36:227–42.PubMedCrossRef Kim WR, Brown JR, Terrault NA, et al. Burden of liver disease in the United States: summary of the workshop. Hepatology. 2002;36:227–42.PubMedCrossRef
2.
Zurück zum Zitat Gines P, Quintero E, Arroyo V, et al. Compensated cirrhosis: natural history and prognostic factors. Hepatology. 1987;7:12–8.CrossRef Gines P, Quintero E, Arroyo V, et al. Compensated cirrhosis: natural history and prognostic factors. Hepatology. 1987;7:12–8.CrossRef
3.
Zurück zum Zitat Powell WJ, Klatskin G. Duration of survival in patients with Laennec’s cirrhosis of the liver. Am J Med. 1968;44:406–20.PubMedCrossRef Powell WJ, Klatskin G. Duration of survival in patients with Laennec’s cirrhosis of the liver. Am J Med. 1968;44:406–20.PubMedCrossRef
4.
Zurück zum Zitat D’Amico G, Morabito A, Pagliaro L, et al. Survival and prognostic indicators in compensated and decompensated cirrhosis. Dig Dis Sci. 1986;31:468–75.PubMedCrossRef D’Amico G, Morabito A, Pagliaro L, et al. Survival and prognostic indicators in compensated and decompensated cirrhosis. Dig Dis Sci. 1986;31:468–75.PubMedCrossRef
5.
Zurück zum Zitat Llach J, Gines P, Arroyo V, et al. Prognostic value of arterial pressure, endogenous vasoconstrictive systems, and renal function in cirrhotic patients admitted to the hospital for the treatment of ascites. Gastroenterology. 1988;94:482–7.PubMed Llach J, Gines P, Arroyo V, et al. Prognostic value of arterial pressure, endogenous vasoconstrictive systems, and renal function in cirrhotic patients admitted to the hospital for the treatment of ascites. Gastroenterology. 1988;94:482–7.PubMed
7.
8.
10.
Zurück zum Zitat Runyon BA. Ascites and spontaneous bacterial peritonitis. In: Feldman M, Friedman LS, Brandt LJ, et al. eds. Sleisenger and Fordtran’s Gastrointestinal and Liver Disease. Philadelphia: Saunders; 2010. Pp. 1517–41 (2) 9. Runyon BA. Ascites and spontaneous bacterial peritonitis. In: Feldman M, Friedman LS, Brandt LJ, et al. eds. Sleisenger and Fordtran’s Gastrointestinal and Liver Disease. Philadelphia: Saunders; 2010. Pp. 1517–41 (2) 9.
12.
Zurück zum Zitat Jansen M, Truong S, Reisener KP, et al. Results of sonographically guided percutaneous catheter drainage of intra-abdominal abscesses in surgery. Chirurg. 1999;70:1168–71.PubMedCrossRef Jansen M, Truong S, Reisener KP, et al. Results of sonographically guided percutaneous catheter drainage of intra-abdominal abscesses in surgery. Chirurg. 1999;70:1168–71.PubMedCrossRef
13.
Zurück zum Zitat Rosenberg SM. Palliation of malignant ascites. Gastroenterol Clin N Am. 2006;35:189–99.CrossRef Rosenberg SM. Palliation of malignant ascites. Gastroenterol Clin N Am. 2006;35:189–99.CrossRef
14.
Zurück zum Zitat Reisfield GM, Wilson GR. Management of intractable cirrhotic ascites with an indwelling drainage catheter. J Palliat Med. 2003;6:787–91.PubMedCrossRef Reisfield GM, Wilson GR. Management of intractable cirrhotic ascites with an indwelling drainage catheter. J Palliat Med. 2003;6:787–91.PubMedCrossRef
15.
Zurück zum Zitat Guevara M, Cardenas A, Uriz J, et al. Prognosis of patients with cirrhosis and ascites. In: Gines P, Arroyo V, Rodes J, Schrier RW, et al. eds. Ascites and Renal Dysfunction in Liver Disease: Pathogenesis, Diagnosis, and Treatment. Malden, Mass: Blackwell Science; 2005. Pp. 260–71.CrossRef Guevara M, Cardenas A, Uriz J, et al. Prognosis of patients with cirrhosis and ascites. In: Gines P, Arroyo V, Rodes J, Schrier RW, et al. eds. Ascites and Renal Dysfunction in Liver Disease: Pathogenesis, Diagnosis, and Treatment. Malden, Mass: Blackwell Science; 2005. Pp. 260–71.CrossRef
16.
Zurück zum Zitat Runyon BA. AASLD practice guidelines committee. Management of adult patients with ascites due to cirrhosis: an update. Hepatology. 2009;49:2087–107.PubMedCrossRef Runyon BA. AASLD practice guidelines committee. Management of adult patients with ascites due to cirrhosis: an update. Hepatology. 2009;49:2087–107.PubMedCrossRef
17.
Zurück zum Zitat Sanyal AJ, Genning C, Reddy RK, et al. The North American study for the treatment of refractory ascites. Gastroenterology. 2003;124:634–41.PubMedCrossRef Sanyal AJ, Genning C, Reddy RK, et al. The North American study for the treatment of refractory ascites. Gastroenterology. 2003;124:634–41.PubMedCrossRef
18.
Zurück zum Zitat Gines P, Uriz J, Calahorra B, et al. Transjugular intrahepatic portosystemic shunting versus paracentesis plus albumin for refractory ascites in cirrhosis. Gastroenterology. 2002;123:1839–47.PubMedCrossRef Gines P, Uriz J, Calahorra B, et al. Transjugular intrahepatic portosystemic shunting versus paracentesis plus albumin for refractory ascites in cirrhosis. Gastroenterology. 2002;123:1839–47.PubMedCrossRef
19.
Zurück zum Zitat Hussain FF, Meer ZF, Lopez AJ. Peritoneovenous shunt insertion for intractable ascites: a district general hospital experience. Cardiovasc Intervent Radiol. 2004;27:325–8.PubMedCrossRef Hussain FF, Meer ZF, Lopez AJ. Peritoneovenous shunt insertion for intractable ascites: a district general hospital experience. Cardiovasc Intervent Radiol. 2004;27:325–8.PubMedCrossRef
20.
Zurück zum Zitat Park JS, Won JY, Park SI, et al. Percutaneous peritoneovenous shunt creation for the treatment of benign and malignant refractory ascites. J Vasc Intervent Radiol. 2001;12:1445–8.CrossRef Park JS, Won JY, Park SI, et al. Percutaneous peritoneovenous shunt creation for the treatment of benign and malignant refractory ascites. J Vasc Intervent Radiol. 2001;12:1445–8.CrossRef
21.
Zurück zum Zitat Rosemurgy AS, Zervos EE, Clark WC, et al. TIPS versus peritoneovenous shunt in the treatment of medically intractable ascites: a prospective randomized trial. Ann Surg. 2004;239:883–91.PubMedCentralPubMedCrossRef Rosemurgy AS, Zervos EE, Clark WC, et al. TIPS versus peritoneovenous shunt in the treatment of medically intractable ascites: a prospective randomized trial. Ann Surg. 2004;239:883–91.PubMedCentralPubMedCrossRef
22.
Zurück zum Zitat Rozenblit GN, Del Guercio LRM, Rundback JH, et al. Peritoneal-urinary drainage for treatment of refractory ascites: a pilot study. J Vasc Intervent Radiol. 1998;9:998–1005.CrossRef Rozenblit GN, Del Guercio LRM, Rundback JH, et al. Peritoneal-urinary drainage for treatment of refractory ascites: a pilot study. J Vasc Intervent Radiol. 1998;9:998–1005.CrossRef
23.
Zurück zum Zitat Lorentzen T, Sengelov L, Nolsoe CP, et al. Ultrasonographically guided insertion of a peritoneo-gastric shunt in patients with malignant ascites. Acta Radiol. 1995;36:481–4.PubMedCrossRef Lorentzen T, Sengelov L, Nolsoe CP, et al. Ultrasonographically guided insertion of a peritoneo-gastric shunt in patients with malignant ascites. Acta Radiol. 1995;36:481–4.PubMedCrossRef
24.
Zurück zum Zitat O'Neill MJ, Weissleder R, Gervais DA, Hahn PF, Mueller PR. Tunneled peritoneal catheter placement under sonographic and fluoroscopic guidance in the palliative treatment of malignant ascites. AJR Am J Roentgenol. 2001;177:615–8. O'Neill MJ, Weissleder R, Gervais DA, Hahn PF, Mueller PR. Tunneled peritoneal catheter placement under sonographic and fluoroscopic guidance in the palliative treatment of malignant ascites. AJR Am J Roentgenol. 2001;177:615–8.
25.
Zurück zum Zitat Richard HM, Coldwell DM, Boyd-Kranis RL, et al. Pleurx tunneled catheter in the management of malignant ascites. J Vasc Intervent Radiol. 2001;12:373–5.CrossRef Richard HM, Coldwell DM, Boyd-Kranis RL, et al. Pleurx tunneled catheter in the management of malignant ascites. J Vasc Intervent Radiol. 2001;12:373–5.CrossRef
26.
Zurück zum Zitat Sartori S, Nielsen I, Trevisani L, et al. Sonographically guided peritoneal catheter placement in the palliation of malignant ascites in end-stage malignancies. AJR Am J Roentgenol. 2002;179:1618–20. Sartori S, Nielsen I, Trevisani L, et al. Sonographically guided peritoneal catheter placement in the palliation of malignant ascites in end-stage malignancies. AJR Am J Roentgenol. 2002;179:1618–20.
27.
Zurück zum Zitat Barnett TD, Rubins J. Placemet of a permanent tunneled peritoneal drainage catheter for palliation of malignant ascites: a simplified percutaneous approach. J Vasc Intervent Radiol. 2002;13:379–83.CrossRef Barnett TD, Rubins J. Placemet of a permanent tunneled peritoneal drainage catheter for palliation of malignant ascites: a simplified percutaneous approach. J Vasc Intervent Radiol. 2002;13:379–83.CrossRef
28.
Zurück zum Zitat Sabatelli FW, Glassman ML, Kerns SR, et al. Permanent indwelling peritoneal access device for the management of malignant ascites. Cardiovasc Intervent Radiol. 1994;17:292–4.PubMedCrossRef Sabatelli FW, Glassman ML, Kerns SR, et al. Permanent indwelling peritoneal access device for the management of malignant ascites. Cardiovasc Intervent Radiol. 1994;17:292–4.PubMedCrossRef
29.
Zurück zum Zitat Rosenblum DI, Geisinger MA, Newman JS, et al. Use of subcutaneous venous access ports to treat refractory ascites. J Vasc Intervent Radiol. 2001;12:1343–6.CrossRef Rosenblum DI, Geisinger MA, Newman JS, et al. Use of subcutaneous venous access ports to treat refractory ascites. J Vasc Intervent Radiol. 2001;12:1343–6.CrossRef
Metadaten
Titel
Central venous pressure catheter for large-volume paracentesis in refractory ascites
verfasst von
Shahram Agah
Sahar Tavakoli
Hajar Nikbakht
Mehrdokht Najafi
Abdolreza Al-agha
Publikationsdatum
01.07.2014
Verlag
Springer India
Erschienen in
Indian Journal of Gastroenterology / Ausgabe 4/2014
Print ISSN: 0254-8860
Elektronische ISSN: 0975-0711
DOI
https://doi.org/10.1007/s12664-014-0448-0

Weitere Artikel der Ausgabe 4/2014

Indian Journal of Gastroenterology 4/2014 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.